|
2025
|
Invention
|
Tablet formulation of tafamidis or pharmaceutically acceptable salt thereof. The present inventio... |
|
|
Invention
|
Tablet formulation of tafamidis or pharmaceutically acceptable salt thereof.
The present inventi... |
|
|
Invention
|
Liquid formulations of lurbinectedin. A ready to use or ready to dilute stable liquid lurbinected... |
|
2024
|
Invention
|
An improved process for preparation of ethiodized oil. An improved process is provided for the pr... |
|
|
Invention
|
Process for isolation of solid ferric derisomaltose. A novel process for isolation of ferric deri... |
|
|
Invention
|
An improved process for preparation of lurbinectedin. The present invention discloses an improved... |
|
|
Invention
|
An improved process for the preparation of solid ferumoxytol. An improved process is provided for... |
|
|
Invention
|
Process for the preparation of solid ferumoxytol.
An improved process is provided for preparatio... |
|
|
Invention
|
Process for preparation of triheptanoin. A process is provided for the preparation of triheptanoi... |
|
|
Invention
|
Process for preparation of triheptanoin.
A process is provided for the preparation of triheptano... |
|
|
Invention
|
Stable solid oral formulation of tafamidis or pharmaceutically acceptable salt thereof.
The pres... |
|
|
Invention
|
Stable solid oral formulation of tafamidis or pharmaceutically acceptable salt thereof. The prese... |
|
|
Invention
|
Rimegepant fast-dissolving films for oral administration. A pharmaceutical composition includes a... |
|
|
Invention
|
Rimegepant suspension. A pharmaceutical composition includes a therapeutically effective amount o... |
|
|
Invention
|
Stable compositions of rilpivirine hcl in combination with other anti-retroviral agents. The pres... |
|
2023
|
Invention
|
Fostemsavir intermediates and process for the preparation thereof. The invention relates to novel... |
|
|
Invention
|
Fostemsavir intermediates and process for the preparation thereof.
The invention relates to nove... |
|
|
Invention
|
Solution formulation of cyclophosphamide.
The present disclosure provides stable liquid formulat... |
|
|
Invention
|
Novel solution formulation of cyclophosphamide. The present disclosure provides stable liquid for... |
|
2022
|
Invention
|
Pharmaceutical preparations of melatonin suitable for intranasal administration.
A pharmaceutica... |
|
|
Invention
|
Process for the preparation of high purity levosimendan. An improved process for the preparation ... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of metal poisoning and alcohol poisoning |
|
2020
|
Invention
|
Bendamustine solution formulations. A ready to use or ready to dilute for use, stable liquid Bend... |
|
|
P/S
|
Pharmaceutical decoctions for the treatment of metal poisoning and alcohol poisoning |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, urea cycle deficiency, metabolic disease... |
|
2017
|
Invention
|
Crystalline fosaprepitant dicyclohexylamine salt and its preparation. Dicyclohexylamine salt of f... |
|
|
Invention
|
Bendamustine solution formulations. Liquid pharmaceutical formulation of Bendamustine that includ... |
|
2016
|
Invention
|
Preparation of pharmaceutical dosage forms containing iron (iii) salts. The present invention pro... |
|
|
P/S
|
Chemicals, namely, precursors and additives all for use in the manufacture of pharmaceuticals |
|
|
Invention
|
Crystalline fosaprepitant dicyclohexylamine salt and its preparation. The present invention provi... |
|
2015
|
Invention
|
Process for the preparation of high purity miglustat. A process for the preparation and isolation... |
|
|
Invention
|
Liquid bendamustine formulation. The present invention provides stable bendamustine-containing ph... |
|
2014
|
Invention
|
Bendamustine hcl stable lyophilized formulations.
The present invention provides a lyophilized b... |
|
|
Invention
|
Process for the preparation of colesevelam hydrochloride. A novel process of manufacturing colese... |
|
|
Invention
|
Direct compression and dry granulation processes for preparing carglumic acid tablets having less... |
|
2012
|
Invention
|
Sustained release suspension preparation for dextromethorphan. A stabilized pharmaceutical compos... |
|
|
Invention
|
Sustained release suspension preparation for dextromethorphan.
A stabilized pharmaceutical compo... |
|
2010
|
Invention
|
Felbamate with improved bulk density.
A synthesis and purification of felbamate, an anticonvulsa... |
|
|
Invention
|
Cross-linked polyallylamine tablet core. A method and a composition for making a composition, tab... |
|
2009
|
Invention
|
Manufacturing process of making polymeric amine salts. A novel process of manufacturing sevelamer... |
|
|
Invention
|
Cross-linked polyallylamine tablet core.
A method and a composition for making a composition, ta... |
|
|
Invention
|
Composition of rapid disintegrating direct compression buccal tablet.
A composition of a rapidly... |
|
|
Invention
|
Manufacture of pure hydralazine salts. The present invention provides an improved process of prep... |
|
|
Invention
|
Concentrated aqueous and/or ethanolic solution of 4-methylpyrazole (fomepizole). A composition of... |
|
|
Invention
|
Concentrated aqueous and/or ethanolic solution of 4-methylpyrazole (fomepizole).
A composition o... |
|
|
Invention
|
Process of making optically pure melphalan. This invention provides a process of making optically... |
|
|
Invention
|
Process of making optically pure melphalan. This invention provides a process of making 4-(bis-(2... |
|
2008
|
Invention
|
Felbamate with improved bulk density. A synthesis and purification of felbamate, an anticonvulsan... |
|
2007
|
Invention
|
Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders.
... |
|
|
Invention
|
Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate. A highly concen... |
|
2006
|
Invention
|
Processes of manufacturing substituted-1,4-dihydropyridines, improved aqueous solutions thereof, ... |
|
|
P/S
|
Chemical precursors and additives for use in the manufacture of pharmaceuticals |
